Market News
White House using Defense Production Act to equip Merck plants for Johnson & Johnson vaccine
NEW YORK (Reuters) - The United States is using the Defense Production Act to equip drugmaker Merck & Co’s plants to make Johnson & Johnson’s just approved COVID-19 vaccine, White House press secretary Jen Psaki said on Tuesday.
“As soon as we learned about the fact that Johnson and Johnson was behind in the manufacturing steps and efforts we took steps to ensure we can expedite that and partner them with one of the world’s biggest manufacturers,” Psaki told a White House briefing.
Reporting by Nandita Bose in Washington; Writing by Michael Erman in New York; Editing by Chris Reese
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.
